| Commonly Used Cardiovascular Drugs and Dosages |
|
Drug
|
Dose
|
|
Amrinone
|
Dog and cat: 1–3 mg/kg, IV, loading dose, then 30–100 μg/kg/min, IV, CRIa
|
|
Amlodipine
|
Dog: 0.1 mg/kg, PO, sid
|
|
|
Cat: 0.18 mg/kg, PO, sid (0.625–1.25 mg/cat, PO, sid)
|
|
Aspirin, antiplatelet
|
Dog: 5–10 mg/kg, PO every 24–48 hr
|
|
|
Cat: 80 mg, PO every 48–72 hr
|
|
Atenolol
|
Dog: 0.25–1 mg/kg, PO, sid-bid, to a maximum dosage of 2–5 mg/kg, PO sid
|
|
|
Cat: 2–3 mg/kg, PO, bid
|
|
Benazepril
|
Dog: 0.25–0.5 mg/kg, PO, sid
|
|
|
Cat: 0.5–1 mg/kg, PO, sid
|
|
Boldenone undecylenateb
|
Horse: 1.1 mg/kg, IM, every 3 wk
|
|
Carvedilol
|
Dog, large breed with dilated cardiomyopathy: starting dose of 3 mg, PO, sid, titrating upward to a maximum of 25–50 mg, PO, divided bid
|
|
|
Dog, small breed with atrioventricular valvular insufficiency: Starting dose of 0.25 mg/kg, PO, bid, titrating upward to a maximum of 1–1.25 mg/kg, PO bid
|
|
Dalteparin
|
Dog and cat: 100–200 IU/kg, SC, sid-bid
|
|
Desmopressin
|
Dog: 0.4 μg/kg, SC; 1 μg/kg in 20 mL saline, IV over 10 min
|
|
Diltiazem
|
Dog: 0.5–1.5 mg/kg, PO tid
|
|
|
Cat: 0.5–2.5 mg/kg, PO, tid
|
|
|
Cat: 10 mg/kg, PO, bid
|
|
|
Cat: 15–30 mg/kg, PO, sid
|
|
Digoxinc
|
Dog: 0.0055–0.011 mg/kg, PO, bid; 0.22 mg/m2, PO, bid
|
|
|
Cat: 0.005–0.01 mg/kg, PO, every 24–48 hr
|
|
Dobutamine
|
Dog: 2–20 μg/kg/min, IV, CRI
|
|
|
Cat: 0.5–10 μg/kg/min, IV, CRI
|
|
Dopamine
|
Dog: 2–15 μg/kg/min, IV, CRI
|
|
|
Horse: 1–5 μg/kg/min, IV, CRI
|
|
Enalaprild
|
Dog and cat: 0.5 mg/kg, PO, sid-bide
|
|
Enoxaparin
|
Dog and cat: 1–2 mg/kg, SC, bid
|
|
Epoetin alfa
|
Dog and cat, initial: 100 U/kg, SC, 3×/wk
|
|
|
Dog and cat, maintenance: 75–100 U/kg, SC, 2–3×/wk
|
|
Folic acid
|
Dog: 5 mg, PO, sid
|
|
|
Cat: 2.5 mg, PO, sid
|
|
Heparin, high dose
|
Dog: 150–250 U/kg, SC, tid
|
|
|
Cat: 250–375 U/kg, SC, bid
|
|
Heparin, low dose
|
Dog and cat: 75 U/kg, SC, tid
|
|
|
Horse: 25–100 U/kg, SC, tid
|
|
Hydralazine
|
Dog: 0.5–3 mg/kg, PO, bid
|
|
|
Cat: 0.5–0.8 mg/kg, PO, bid
|
|
Iron (dextrans)f
|
Pig, neonate: 100 mg, IMe
|
|
Iron (ferrous sulfate)
|
Dog: 100–300 mg, PO, sid
|
|
|
Cat: 50–100 mg, PO, sid
|
|
Lidocaineg
|
Dog: 1–2 mg/kg, IV; 40–80 μg/kg/min, IV, CRI
|
|
Mexiletine
|
Dog: 4–10 mg/kg, PO, tid
|
|
Nandrolone decanoate
|
Dog: 1–1.5 mg/kg, IM, weekly
|
|
|
Cat: 1 mg/kg, IM, weekly
|
|
|
Horse: 1 mg/kg, IM, every 4 wk
|
|
Nitroglycerin ointment (1 in. = 15 mg)
|
Dog: 4–15 mg, topically, tid
|
|
|
Cat: 2–4 mg, topically, tid
|
|
Nitroprusside
|
Dog: 1–10 μg/kg/min, IV, CRI
|
|
Oxymetholone
|
Dog and cat: 1–5 mg/kg, PO, every 18–24 hr
|
|
Phenytoin
|
Dog: 30–50 mg/kg, PO, tid
|
|
Pimobendanh
|
Dog: 0.5 mg/kg, PO, daily, divided bid
|
|
|
Cat: 0.625 mg/kg, PO, sid-bid
|
|
Procainamide
|
Dog: 10–30 mg/kg, PO, qid; 10–40 μg/kg/min, IV, CRI
|
|
|
Cat: 3–8 mg/kg, PO, tid-qid; 10–20 μg/kg/min, IV, CRI
|
|
|
Horse: 25–35 mg/kg, PO, tid; 1 mg/kg/min, IV to a maximum of 20 mg/kg
|
|
Propranolol
|
Dog: 0.1–2 mg/kg, PO, tid
|
|
|
Cat: 2.5–5 mg/cat, PO, tid
|
|
Quinidine sulfate
|
Dog and cat: 4–20 mg/kg, PO, tid-qid
|
|
|
Horse: 22 mg/kg, PO every 2 hr
|
|
Quinidine gluconate
|
Horse: 1–1.5 mg/kg, IV every 5–10 min
|
|
Tocainide
|
Dog: 15–20 mg/kg, PO, tid
|
|
tPA
|
Cat: 0.25–1 mg/kg/hr, IV (total dose 1–10 mg/kg)
|
|
Vitamin B12f
|
Dog: 100–200 μg, PO or SC, sid
|
|
|
Cat: 50–100 μg, PO or SC, sid
|
|
Warfarin sodium
|
Dog and cat: 0.1–0.2 mg/kg, PO, sid
|
|
|
Horse: 0.067–0.167 mg/kg, PO, sid
|
|
a CRI = continuous rate infusion
|
|
b Approved by FDA for adjunctive therapy in treating debilitated horses.
|
|
c Approved by FDA for initial and chronic treatment of heart failure and supraventricular tachycardia, atrial flutter, and atrial fibrillation in dogs.
|
|
d Approved by FDA for treatment of mild, moderate, or severe heart failure in dogs due to mitral regurgitation and/or reduced ventricular contractility.
|
|
e FDA/CVM approved dosage regimen
|
|
f Several FDA-approved products are available.
|
|
g Several FDA-approved products are available; however, none are specifically approved for control of cardiac arrhythmias.
|
|
h Approved by FDA for management of the signs of mild, moderate, or severe CHF in dogs due to atrioventricular valvular insufficiency or dilated cardiomyopathy.
|
|